Orchid Delays Release of 2004 10-K Due to December Departure of CFO Spicer | GenomeWeb

NEW YORK, March 18 (GenomeWeb News) - Orchid Biosciences has delayed the release of its 10-K 2004 earnings report due to the recent departure of CFO Mike Spicer, and because the SEC now considers Orchid to be an accelerated filer, the company said in a document filed with the SEC yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.